ProQuest Associates IV LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 54,180 shares at $89.09 ($4.8M) on 2017-04-25, disclosed to the SEC on 2017-04-27.
Open-market sale of $4.8M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.34 | 51,219 | $4.5M | 94.5% |
| 2 | $89.09 | 2,961 | $264K | 5.5% |
| Total | $88.38 avg | 54,180 | $4.8M | 100% |
| Filing → |
| EGRX | SELL | 2016-11-14 | $4.2M | — | Filing → |
| EGRX | SELL | 2016-11-04 | $21.0M | — | Filing → |
| EGRX | SELL | 2016-09-30 | $10.9M | — | Filing → |